'Superbowl' kicks off drug delivery revolution

September 14, 2010
'Superbowl' drug revolutionary
The superbowl promises more accurate drug dose delivery.

Scientists from Australian National University have developed a 'Superbowl' drug delivery system that promises more accurate doses of drugs with fewer side effects.

The researchers, led by Associate Professor Michael Sherburn from the ARC Centre of Excellence for Free Radical Chemistry and Biotechnology at ANU, have created a molecule - dubbed the ‘Superbowl’ - which can capture, hold and deliver drugs.

“Excitingly, unlike conventional capsules, we can control the rate at which a drug is released from our superbowl container molecule,” said Associate Professor Sherburn. “This has the potential to allow lower drug doses, hence leading to fewer side-effects.”

The group have already successfully put inside the superbowl and are now working on incorporating drugs to treat other diseases, including cancers, arthritis and .

“We have shown that drug release can be controlled at the most precise level, which is very encouraging for the future of ,” said Associate Professor Sherburn.

The superbowl has been created using free radical chemistry. Free radicals are highly reactive molecules that often attract negative attention due to the damage they can do to materials and health. However when controlled and harnessed, can be used to complete difficult chemical reactions, such as those required to produce the superbowl that would otherwise not be possible.

The first organic container molecules were developed in the 1980s. These early examples could encapsulate only very small entities consisting of a few atoms, and they did so without any selectivity. The superbowl is significant because its large capacity allows it to carry useful molecules, such as drugs, with up to a hundred .

“The next step is to design container molecules that can target specific locations in the body. The ultimate goal of this research is safer and more effective use of medicines,” he added.

Explore further: Light activated anticancer drug targeted to DNA using cisplatin like sub-units

More information: Their researchers’ work has recently been published in The Royal Society Chemistry journal, Chemical Communications.

Related Stories

Developing a modular, nanoparticle drug delivery system

October 6, 2007

There are two aspects to creating an effective drug: finding a chemical compound that has the desired biological effect and minimal side-effects and then delivering it to the right place in the body for it to do its job. ...

Rosemary chicken protects your brain from free radicals

October 30, 2007

Rosemary not only tastes good in culinary dishes such as Rosemary chicken and lamb, but scientists have now found it is also good for your brain. A collaborative group from the Burnham Institute for Medical Research (Burnham ...

Inflammatory diseases: Scientists identify antiviral defense

June 15, 2010

Canadian researchers have discovered a new way the body combats respiratory viral infections. In the prestigious journal PLoS Pathogens, scientists from the University of Montreal and the University of Montreal Hospital Research ...

Recommended for you

Yarn from slaughterhouse waste

July 29, 2015

ETH researchers have developed a yarn from ordinary gelatine that has good qualities similar to those of merino wool fibers. Now they are working on making the yarn even more water resistant.

Findings illuminate animal evolution in protein function

July 27, 2015

Virginia Commonwealth University and University of Richmond researchers recently teamed up to explore the inner workings of cells and shed light on the 400–600 million years of evolution between humans and early animals ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.